Quantum precision reached in modeling molten salt behavior
Inspired by one of the mysteries of human perception, an ORNL researcher invented a new way to hide sensitive electric grid information from cyberattack: within a constantly changing color palette.
A trio of new and improved cosmological simulation codes was unveiled in a series of presentations at the annual April Meeting of the American Physical Society in Minneapolis.
Climate change often comes down to how it affects water, whether it’s for drinking, electricity generation, or how flooding affects people and infrastructure. To better understand these impacts, ORNL water resources engineer Sudershan Gangrade is integrating knowledge ranging from large-scale climate projections to local meteorology and hydrology and using high-performance computing to create a holistic view of the future.
Oak Ridge National Laboratory scientists exploring bioenergy plant genetics have made a surprising discovery: a protein domain that could lead to new COVID-19 treatments.
Researchers at ORNL have developed a machine-learning inspired software package that provides end-to-end image analysis of electron and scanning probe microscopy images.
A team of researchers from ORNL was recognized by the National Cancer Institute in March for their unique contributions in the fight against cancer.
Oak Ridge National Laboratory, in partnership with the National Oceanic and Atmospheric Administration, is launching a new supercomputer dedicated to climate science research. The new system is the fifth supercomputer to be installed and run by the National Climate-Computing Research Center at ORNL.
ORNL has named Michael Parks director of the Computer Science and Mathematics Division within ORNL’s Computing and Computational Sciences Directorate. His hiring became effective March 13.
How did we get from stardust to where we are today? That’s the question NASA scientist Andrew Needham has pondered his entire career.
A team of scientists led by the Department of Energy’s Oak Ridge National Laboratory designed a molecule that disrupts the infection mechanism of the SARS-CoV-2 coronavirus and could be used to develop new treatments for COVID-19 and other viral diseases.